Table 2. Laboratory Findings of Patients Infected With SARS-CoV-2.
|
All patients (n=50) |
Required supplemental O2 (n=37) |
Did not require supplemental O2 (n=13) |
pa | |
| Blood routine, median (range) | ||||
| Leucocytes (× 103 per µl; normal range: 3·5–9) | 5.80 (2.40-9.80) | 6.10 (2.60-9.80) | 4.70 (2.40-8.10) | 0.18 |
| Neutrophils %; normal range: 40-70 | 72.20 (48.2-86.7) | 70.60 (48.2-86.7) | 72.90 (59.4-85.6) | 0.32 |
| Lymphocytes %; normal range: 20-50 | 19.10 (7.3-42.0) | 20.15 (8.8-42) | 18 (7.3-33.6) | 0.33 |
| Platelets (× 103 per µl; normal range 150–450) | 176 (100-436) | 185 (100-436) | 154 (105-228) | 0.07 |
| Hemoglobin (g/dl; normal range 13.5-18) | 12.5 (3.2-18.1) | 12.3 (7.7-18.1) | 12.8 (3.2-14.7) | 0.85 |
| Coagulation function | ||||
| Prothrombin time (s; normal range 12-14) | 13.20 (12-15.3) | 13.2 (12-15.3) | 12.95 (12-14.3) | 0.61 |
| partial thromboplastin time (s; normal range 25-45) | 33 (25-64) | 31.60 (25-64) | 34 (31-36) | 0.86 |
| International Normalized Ratio (S) | 1.10 (1-1.40) | 1.10 (1.00-1.40) | 1.06 (1.00-1.25) | 0.54 |
| Blood biochemistry, median(range) | ||||
| Alanine aminotransferase (U/L; normal range :up to 41) | 31 (15-237) | 31 (15-237) | 32.50 (22-46) | 0.73 |
| Aspartate aminotransferase (U/L; normal range: up to 37) | 36 (14-203) | 37 (14-203) | 35.50 (21-53) | 0.43 |
| Alkaline phosphatase(U/L; normal range: 98- 279) | 157 (59-273) | 158 (85-273) | 133.50 (59-167) | 0.04 |
| Total bilirubin (mg/dl; normal range 0·1–1.2) | 0.8 (0.4-3.3) | 0.8 (0.5-3.5) | 0.55 (0.4-0.7) | <0.001 |
| Serum creatinine (mg/dl; normal range 0.6-1.3) | 0.90 (0.6-5.6) | 0.9 (0.6-5.6) | 1.05 (0.7-1.7) | 0.32 |
| Urea( mg/dl; normal range: 11-55) | 34 (13-128) | 33 (19-128) | 37 (13-64) | 0.73 |
| Lactate dehydrogenase (U/L; normal range 120–460) | 476.50 (284-1247) | 516 (340-1274) | 409 (284-625) | 0.02 |
| Glucose (mg/dl; normal range<140) | 95 (71-409) | 97 (72-324) | 90 (71-409) | 0.85 |
| Albumin (gr/dl; normal range 3.5-5): n=3 | 4 (3.7-4.1) | 4 (3.7-4.1) | - | - |
| Troponin I (ng/l; normal range<19): n=10 | 5.2 (1.20-29.20) | 5.4 (1.40-29.20) | 1.6 (1.20-6.90) | 0.28 |
| Creatine phosphokinase (CPK)( mg/dl; normal range 24-195): n=5 | 163 (58-501) | 163 (76-225) | 279 (58-501) | 0.67 |
| Ferritin (ng/ml; normal range: 4.63-204) n=8 | 589.85 (87.99-2560) | 589.850 (87.99-2560) | - | - |
| PH ( normal range 7.35-7.45): n=13 | 7.44 (7.32-7.50) | 7.44 (7.32-7.50) | 7.42 (7.40-7.46) | 0.54 |
| HCO3- (mmol/l; normal range 24): n=13 | 23.20 (16.80-30.5) | 23.10 (16.80-27.10) | 29 (23.10-30.5) | 0.06 |
| Infection-related biomarkers | ||||
| Erythrocyte sedimentation rate (mm/h; normal Range 0·0–15·0) | 38 (4-108) | 38 (4-108) | 38 (22-68) | 0.9 |
| C-reactive protein (qualitative; normal range 0) | 2.50 (0-3) | 2 (0-3) | 3 (0-3) | 0.95 |
a. P values indicate differences between O2 supplemented and non- O2 supplemented patients. P < .05 was considered statistically significant.